NBE870/pNB268 [FD29389] (ATCC® 69355)

Applications: expression vectorshuttle vector  /  Depositors: Pfizer, Inc., LH Huang, Pfizer, Inc.

Permits and Restrictions

View Permits

Designations NBE870/pNB268 [FD29389]
U.S. Patent
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Depositors Pfizer, Inc., LH Huang, Pfizer, Inc.
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Vector Information
Construct size (kb): 9.899999618530273
expression vector
shuttle vector
Restriction digests of the clone give the following sizes (kb): EcoRI--7.6, 1.7, 0.9; BamHI--10.2; HindIII--7.4, 2.7.
Constructed from a HindIII/EcoRI fragment (3.0 kb) containing XPR2-derived sequence, an MCS, and a terminator region, and from a partial EcoRI fragment (2.5 kb) containing LEU2.
Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Growth Conditions
Temperature: 37.0°C

Liang H Huang, personal communication

Shipped freeze-dried
Shipping Information

Shipped:  Freeze dried Escherichia coli containing the phagemid.